ES71
TEAS SECTION 71 RECEIVED
16/07/2026
Voltar para busca
Dado oficial do USPTO
BIOLUMI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
08/07/2015
Data de registro
27/09/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/05/2022
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Shenzhen, Guangdong, CN
Examinador
SEVERSON, KAREN
Unidade examinadora
M80
Descrição da marca
The mark consists of wording "BIOLUMI" in stylized font.
Titulares e representantes
Titulares
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representantes
Stacy L. Emhoff Walker & Jocke Co., LPA
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drugs for medical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin disease; chemical preparations for the diagnosis of pregnancy; Medicated serums for invitro diagnosis of pregnancy and treatment of blood conditions during pregnancy; Serotherapeutic medicines for the treatment of hepatitis; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; Chemical preparations for pharmaceutical purposesfor diagnosis or treatment of tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposesfor diagnosing or detecting tumorsthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesTORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes
Classe 10
Blood testing apparatus; massage apparatus; Testing apparatus for medical purposesmedical testing instrument for testing blood samplesbody fluids and body tissue samples; Apparatus for use in medical analysismedical analyzer for analysis of blood samplesbody fluids and body tissue samples;Diagnostic apparatus for medical purposesmedical diagnostic analyzer for analyzing blood samplesbody fluids and body tissue samples; radiotherapy apparatus; Ultrasonic devices for medical useclinical ultrasonic diagnostic apparatus; artificial limbs; Multifunction corsets for medical purposediagnosis and therapeutic corsets for medical purpose; suture materials
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
27/09/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/07/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
18/04/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/03/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
13/03/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
19/01/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19/05/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
19/05/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/05/2022
PR71
POST REGISTRATION ACTION MAILED - SEC.71
30/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/04/2022
ES71
TEAS SECTION 71 RECEIVED
27/09/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
20/02/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/06/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
29/12/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
29/12/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/07/2016
PUBO
PUBLISHED FOR OPPOSITION
12/07/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/06/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/06/2016
NPUB
NOTICE OF PUBLICATION
22/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2016
CNRT
NON-FINAL ACTION MAILED
27/01/2016
CNRT
NON-FINAL ACTION WRITTEN
27/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2016
ALIE
ASSIGNED TO LIE
22/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2016
RFNT
REFUSAL PROCESSED BY IB
05/01/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/12/2015
RFRR
REFUSAL PROCESSED BY MPU
16/12/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/12/2015
MAFR
APPLICATION FILING RECEIPT MAILED
15/12/2015
CNRT
NON-FINAL ACTION WRITTEN
14/12/2015
DOCK
ASSIGNED TO EXAMINER
11/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/12/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOLUMI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.